共 50 条
The value of glial fibrillary acidic protein levels in the diagnosis and prognosis of subarachnoid hemorrhage
被引:2
|作者:
Tatli, Ozgur
[1
]
Yadigaroglu, Metin
[1
]
Demir, Selim
[2
]
Dogramaci, Seniz
[3
]
Cicek, Mustafa
[1
]
Imamoglu, Melih
[1
]
Pasli, Sinan
[1
]
Ardic, Senol
[4
]
Mentese, Ahmet
[5
]
Turedi, Suleyman
[1
]
机构:
[1] Karadeniz Tech Univ, Fac Med, Dept Emergency Med, TR-61080 Trabzon, Turkey
[2] Karadeniz Tech Univ, Fac Hlth Sci, Dept Nutr & Dietet, Trabzon, Turkey
[3] Karadeniz Tech Univ, Fac Med, Dept Biochem, Trabzon, Turkey
[4] Univ Hlth Sci, Fac Med, Dept Emergency Med, Trabzon, Turkey
[5] Karadeniz Tech Univ, Vocat Sch Hlth Sci, Program Med Lab Tech, Trabzon, Turkey
关键词:
Subarachnoid hemorrhage;
glial fibrillary acidic protein;
diagnosis;
prognosis;
TRAUMATIC BRAIN-INJURY;
INTRACRANIAL LESIONS;
SERUM-CONCENTRATIONS;
BIOMARKERS;
MANAGEMENT;
S100-BETA;
VASOSPASM;
MILD;
GFAP;
D O I:
10.1177/1024907920915054
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Background: Subarachnoid hemorrhages is an important emergency condition due to its high morbidity and mortality. Early diagnosis and rapid intervention are very important to prevent poor clinical outcome of this disease. Objective: The aim of this study was to determine the value of glial fibrillary acidic protein in the diagnosis and prognosis of subarachnoid hemorrhage. Methods: Patients presenting to the emergency department and undergoing computerized tomography and/or lumbar puncture due to suspicion of subarachnoid hemorrhage were included in this prospective study. Based on the computerized tomography-lumbar puncture results, cases were divided into subarachnoid hemorrhage group and non-subarachnoid hemorrhage control group. Subarachnoid hemorrhage patients were classified on the basis of severity of subarachnoid hemorrhage and were classified as good or poor clinical outcome groups based on Glasgow Outcome Scores. Glial fibrillary acidic protein levels were then compared. Results: A total of 111 patients were evaluated due to suspicion of subarachnoid hemorrhage and diagnosed with subarachnoid hemorrhage (n = 73) or without subarachnoid hemorrhage (n = 38). Cerebrospinal fluid glial fibrillary acidic protein levels were significantly higher in the subarachnoid hemorrhage group than in the non-subarachnoid hemorrhage group (p < 0.001) (median (25%-75%): 11.62 (2.64-68.04) and 2.26 (1.5-4.83), respectively). Serum glial fibrillary acidic protein levels of the subarachnoid hemorrhage patients with poor clinical outcomes were higher than those of subarachnoid hemorrhage patients with good clinical outcomes (p = 0.003) and cerebrospinal fluid glial fibrillary acidic protein levels were similar (p = 0.379). Glial fibrillary acidic protein levels at the time of presentation exhibited a low level of correlation with Glasgow coma score, World Federation of Neurological Surgeons scale, Hunter-Hess Scale, Ogilvy-Carter Scale, Glasgow Outcome Score, and modified Rankin score. Conclusion: Cerebrospinal fluid glial fibrillary acidic protein levels may be a valuable diagnostic parameter at the time of presentation for diagnosis of subarachnoid hemorrhage. And also serum glial fibrillary acidic protein levels may be useful in predicting subarachnoid hemorrhage patients with poor clinical outcomes.
引用
收藏
页码:151 / 160
页数:10
相关论文